Elevated urinary total sialic acid and increased oxidative stress in patients with bladder cancer

Asian Biomedicine

Volumn 4, Issue 5, 2010, Pages 703-710

  Opanuraks, Julin ^a   Boonla, Chanchai ^a   Saelim, Chawalit ^a   Kittikowit, Wipawee ^a   Sumpatanukul, Pichet ^a   Honglertsakul, Chavalit ^a   Tosukhowong, Piyaratana ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

8 OHdG; Bladder cancer; Oxidative stress; Transitional cell carcinoma; Urinary sialic acid

Indexed keywords

EID: 84871690157     PISSN: 19057415     EISSN: 1875855X     Source Type: Journal    
DOI: 10.2478/abm-2010-0092     Document Type: Article

References (43)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58:71-96. (Pubitemid 351521864)
2. McNeil BK, Getzenberg RH. Urine-based markers in bladder cancer: future prospects. BJU Int. 2008; 101:668-9. (Pubitemid 351270009)
3. Sriplung S. Urinary bladder. In Khuhaprema T, Srivatanakul P, Sriplung H, Wiangnon S, Sumitsawan Y, Attasara P eds, Cancer in Thailand Vol IV 1998-2000 Bangkok: Bangkok Medical Publisher, 2007: p. 61-2.
4. Sanchez-Carbayo M. Recent advances in bladder cancer diagnostics. Clin Biochem. 2004; 37:562-71. (Pubitemid 38845019)
5. Miyagi T, Wada T, Yamaguchi K, Hata K. Sialidase and malignancy: a minireview. Glycoconj J. 2004; 20:189-98. (Pubitemid 39024047)
6. Kannagi R. Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited. Glycoconj J. 2004; 20:353-64. (Pubitemid 39024043)
7. Crook M. The determination of plasma or serum sialic acid. Clin Biochem. 1993; 26:31-38. (Pubitemid 23060969)
8. Narayanan S. Sialic acid as a tumor marker. Ann Clin Lab Sci. 1994; 24:376-84. (Pubitemid 24203481)
9. Sillanaukee P, Ponnio M, Jaaskelainen IP. Occurrence of sialic acids in healthy humans and different disorders. Eur J Clin Invest. 1999; 29:413-25. (Pubitemid 29209762)
10. Patel PS, Baxi BR, Adhvaryu SG, Balar DB. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma. Anticancer Res. 1990; 10:1071-4. (Pubitemid 20239529)
11. Feijoo C, Paez de la Cadena M, Rodriguez-Berrocal FJ, Martinez-Zorzano VS. Sialic acid levels in serum and tissue from colorectal cancer patients. Cancer Lett. 1997; 112:155-60. (Pubitemid 27104290)
12. Wongkham S, Boonla C, Kongkham S, Wongkham C, Bhudhisawasdi V, Sripa B. Serum total sialic acid in cholangiocarcinoma patients: an ROC curve analysis. Clin Biochem. 2001; 34:537-41. (Pubitemid 34014846)
13. Hobarth K, Hofbauer J, Fang-Kircher S. Plasma sialic acid in patients with prostate cancer. Br J Urol. 1993; 72:621-4. (Pubitemid 23357189)
14. Dunzendorfer U, Katopodis N, Dnistrian AM, Stock CC, Schwartz MK, Whitmore WF, Jr. Plasma lipid bound sialic acid in patients with prostate and bladder cancer. Invest Urol. 1981; 19:194-6. (Pubitemid 12236426)
15. Oztokatli A, Ozkardes H, Ovul E, Erol D. The significance of serum lipid-bound sialic acid in bladder tumours. Int Urol Nephrol. 1992; 24:125-9.
16. Lagana A, Pardo-Martinez B, Marino A, Fago G, Bizzarri M. Determination of serum total lipid and free N-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of free N-acetylneuraminic acid as tumour marker. Clin Chim Acta. 1995; 243:165-79.
17. Akcay T, Konukoglu D, Erosenci A, Ataus S, Dirican A, Uygur C. Urinary excretion of sialic acid in patients with superficial bladder tumors. Cancer Lett. 1994; 78:7-9. (Pubitemid 24129075)
18. Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol. 2004; 44:239-67. (Pubitemid 38263841)
19. Akcay T, Saygili I, Andican G, Yalcin V. Increased formation of 8-hydroxy-2'-deoxyguanosine in peripheral blood leukocytes in bladder cancer. Urol Int. 2003; 71:271-4. (Pubitemid 37186742)
20. Chiou CC, Chang PY, Chan EC, Wu TL, Tsao KC, Wu JT. Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers. Clin Chim Acta. 2003; 334:87-94. (Pubitemid 36836061)
21. Badjatia N, Satyam A, Singh P, Seth A, Sharma A. Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma. Urol Oncol. 2010; 28:360-7.
22. Hoogwerf BJ, Laine DC, Greene E. Urine C-peptide and creatinine (Jaffe method) excretion in healthy young adults on varied diets: sustained effects of varied carbohydrate, protein, and meat content. Am J Clin Nutr. 1986; 43:350-60. (Pubitemid 16097194)
23. Aminoff D. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem J. 1961; 81:384-92.
24. Marshall PJ, Warso MA, Lands WE. Selective microdetermination of lipid hydroperoxides. Anal Biochem. 1985; 145:192-9. (Pubitemid 15143096)
25. Taylor JA, 3rd, Kuchel GA. Bladder cancer in the elderly: clinical outcomes, basic mechanisms, and future research direction. Nat Clin Pract Urol. 2009; 6:135-44.
26. Mitra AP, Cote RJ. Molecular pathogenesis and diagnostics of bladder cancer. Annu Rev Pathol. 2009; 4:251-85.
27. De Vizcaya-Ruiz A, Barbier O, Ruiz-Ramos R, Cebrian ME. Biomarkers of oxidative stress and damage in human populations exposed to arsenic. Mutat Res. 2009; 674:85-92.
28. Konety BR, Getzenberg RH. Urine based markers of urological malignancy. J Urol. 2001; 165:600-11. (Pubitemid 32060487)
29. Konukoglu D, Akcay T, Celik C, Erozenci A. Urinary excretion of sialic acid in patients with bladder tumors. Cancer Lett. 1995; 94:97-100.
30. Basoglu M, Atamanalp SS, Yildirgan MI, Aydinli B, Ozturk G, Akcay F, et al. Correlation between the serum values of soluble intercellular adhesion molecule-1 and total sialic acid levels in patients with breast cancer. Eur Surg Res. 2007; 39:136-40. (Pubitemid 46633174)
31. Sebzda T, Saleh Y, Gburek J, Warwas M, Andrzejak R, Siewinski M, et al. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage. J Exp Ther Oncol. 2006; 5:223-9. (Pubitemid 43843832)
32. Kakari S, Stringou E, Toumbis M, Ferderigos AS, Poulaki E, Chondros K, et al. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid. Anticancer Res. 1991; 11:2107-10.
33. Reganon E, Vila V, Martinez-Sales V, Vaya A, Mira Y, Ferrando F, et al. Sialic acid is an inflammation marker associated with a history of deep vein thrombosis. Thromb Res. 2007; 119:73-8. (Pubitemid 44716208)
34. Ekin S, Mert N, Gunduz H, Meral I. Serum sialic acid levels and selected mineral status in patients with type 2 diabetes mellitus. Biol Trace Elem Res. 2003; 94:193-201. (Pubitemid 37159517)
35. Goswami K, Nandeesha H, Koner BC, Nandakumar DN. A comparative study of serum protein-bound sialic acid in benign and malignant prostatic growth: possible role of oxidative stress in sialic acid homeostasis. Prostate Cancer Prostatic Dis. 2007; 10:356-59. (Pubitemid 350238084)
36. Yalcin O, Karatas F, Erulas FA, Ozdemir E. The levels of glutathione peroxidase, vitamin A, E, C and lipid peroxidation in patients with transitional cell carcinoma of the bladder. BJU Int. 2004; 93:863-6. (Pubitemid 38497044)
37. Arikan S, Akcay T, Konukoglu D, Obek C, Kural AR. The relationship between antioxidant enzymes and bladder cancer. Neoplasma. 2005; 52:314-7. (Pubitemid 41076199)
38. Jacobs EJ, Henion AK, Briggs PJ, Connell CJ, McCullough ML, Jonas CR, et al. Vitamin C and vitamin E supplement use and bladder cancer mortality in a large cohort of US men and women. Am J Epidemiol. 2002; 156:1002-10. (Pubitemid 35396929)
39. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol. 2004; 21:392-401.
40. Tian B, Wang Z, Zhao Y, Wang D, Li Y, Ma L, et al. Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model. Cancer Lett. 2008; 264:299-308.
41. Patumraj S, Yoisungneon P. Curcumin as a therapeutic agent against cancer. Asian Biomed. 2007; 1:239-52.
42. Brinkman M, Buntinx F, Muls E, Zeegers MP. Use of selenium in chemoprevention of bladder cancer. Lancet Oncol. 2006; 7:766-74. (Pubitemid 44283670)
43. Kurtul N, Cil MY, Pacaci SD. Serum total sialic acid levels in smokers and users of smokeless tobacco in form of oral powder (Maras powder). J Biomed Sci. 2005; 12:559-63. (Pubitemid 41032319)